| Biomarker ID | 1253 |
| PMID | 24266816 |
| Year | 2013 |
| Biomarker | Osteopontin (OPN) |
| Biomarker Basis | Concentration Based (ng/mL) |
| Biomolecule | Protein |
| Source | Urine |
| Subjects | Humans |
| Regulation | Upregulated in PCa: [Localised PCa: 613.6; Metastaic PCa: 1024] |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Localised Vs Metastatic Prostate Cancer |
| Type of Biomarker | Prognostic |
| Cohort | Healthy men (n = 19) and men with localized (n = 65) and metastatic (n = 36) Prostate Cancer were chosen as the cohort |
| Senstivity | 65% |
| Specificity | 36% |
| AUC | 0.68 (95% CI: 0.56–0.79) |
| Accuracy | NA |
| Level Of Significance | p = 0.003 |
| Method Used | ELISA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |